FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Health System Strengthening

WHO Living Guideline: Drugs to Prevent COVID-19

02 Dec 2021

Current use of drugs to prevent COVID-19 is variable, with a high level of uncertainty regarding the evidence-base, and numerous randomized clinical trials of many different drugs underway to inform practice. The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19.  This document includes a strong recommendation against administering hydroxychloroquine prophylaxis to individuals who do not have COVID-19.  This living guideline is an innovation from WHO, driven by the urgent need for global collaboration to provide trustworthy and evolving COVID-19 guidance informing policy and practice worldwide. This is a useful document for policy makers. Click here to read the guideline. 

PUBLISHED BY
World Health Organization
YEAR OF PUBLISHING
2021
AUTHORS
World Health Organization

Categories

COVID-19 For policymakers
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2023 Swasti Health Catalyst